Live Online Training - Lab Data Integrity - Meeting FDA & EU Concerns
22/23 September 2020
Course No. 18301
Objectives
The learning objectives are firstly, understand the data integrity requirements of a GMP regulated laboratory in Pharmaceutical organisations and contract labs and secondly, how laboratory personnel can ensure compliance and be able to defend their positions. Records generated by three processes will be taken through the presentations and workshops: paper only with records maintained in a laboratory notebook or controlled sheets, hybrid system with signed paper records with underlying electronic records and an electronic system using electronic signatures. Second person review is a critical process that needs to be thorough and effective to ensure that data issues are picked up and resolved.
Background
Data Integrity is currently the major concern with both the FDA and European Regulatory Agencies. Many FDA warning letters and EU GMP inspections have highlighted major data integrity failures at companies globally. The regulatory concern has been responded by the FDA issuing Compliance Program Guide (CPG) 7346.832 that covers Pre-Approval Inspections. This document became effective in May 2012 after Agency inspectors received training in Data Integrity where they focus on computer systems and not the paper output. The CPG objective 3 covers the laboratory data integrity audit. In April 2016 a draft Data Integrity guidance was issued for industry comment.
In March 2015, also MHRA issued an updated Data Integrity Guidance containing an expansion of the expectations of Data Integrity governance together with a list of 19 definitions and expectations for each one. Followed in July 2016 by a more general guidance for GXP data integrity.
In June 2016, the World Health Organisation issued a final version of a guidance document which provides a more encompassing explanation of Data Integrity and also data governance expectations for regulated healthcare companies. EMA and PIC/S both issued draft Data Integrity guidance documents in August 2016. ECA have published two versions of Data Governance and Data Integrity guidance in 2016 and 2018. The GAMP Forum has published a Guide on Records and Data Integrity in 2017 and the first of three Good Practice Guides on Data Integrity - Key Concepts. Lastly, PDA has also issued a guidance document for pharmaceutical laboratories in August 2018.
The emphasis of all regulators is on the ALCOA principles to outline regulatory expectations for ways to ensure the integrity of data over the life cycle.
The Live Online Training focuses on three types of records that can be found in analytical laboratories working to GMP: paper, hybrid computerized system and electronic workflows with electronic signatures. Through presentations, workshops and Q&A sessions attendees are taken through the process from analysis to generation of results to understand Data Integrity issues.
Target Group
This Live Online Training will be of significant value to:
Managers and scientists from Quality Control and Analytical Development Laboratories wanting to understand the Data Integrity and audit process
Quality Assurance personnel
Contract Research Organisation and Contract Manufacturing Organisation laboratory and QA personnel
Auditors (internal and external) responsible for assessing laboratory quality and Data Integrity
Technical Requirements
For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.
At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.
Programme
Establishing the Controls for Ensuring Laboratory Data Integrity
EU and FDA GMP Regulations Impacting Laboratory Data and Results
EU GMP requirements
MHRA and WHO Data Integrity Guidances
FDA GMP requirements
FDA Guidance documents OOS, Inspection of QC labs
Inspection findings 483 and warning letters
Defining Data Integrity, “complete data” and „raw data“
Principles for the Generation of Data
Observational tests and instrument tests
Training of staff
Qualified analytical instruments and validated software
Integrity issues
Application of ALCOA+ principles
WORKSHOP I: Generation of Data
What are the requirements for raw data integrity?
Three scenarios covering
a paper system
a hybrid system
a client server electronic system
Processing and Reporting of Data
Paper / hybrid based systems
Networked systems with electronic records and
signatures
Calculations and transformation of data manually and by computer applications
Application of ALCOA+ principles to the process
Calculating the reportable value and comparison with the specification
Paper processes versus electronic processes
Linkage with out of specification investigations (OOS)
WORKSHOP II: Processing and Reporting of Data
Reviewing an analytical record
Scenario covering paper-based record and an electronic system
Second Person Review of Data
Role of the second person review
Determination that the reportable result is correctly calculated
Identification and correction of errors for paper and electronic systems
Do you have complete data?
WORKSHOP III: Second Person Review of Data
Application of ALCOA+ principles for the review of paper records
WORKSHOP IV: Investigating Out of Specification Results
Key Learning Points and Final Q & A Session
This training/webinar cannot be booked. Send us your inquiry by using the following contact form.
To find alternative dates for this training/webinar or similar events please see the complete list of all events.
For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.
Testimonials
